Salvage treatment of disseminated strongyloidiasis in an immunocompromised patient: therapy success with subcutaneous ivermectin

Braz J Infect Dis. 2012 Sep-Oct;16(5):479-81. doi: 10.1016/j.bjid.2012.08.008. Epub 2012 Sep 10.


Disseminated strongyloidiasis is a disease with high mortality rate, especially in immunocompromised individuals. Paralytic ileus and intestinal malabsorption are frequent symptoms caused by this severe disease. As there are no licensed parenteral anthelmintic drugs for human use, off-label formulations are often used in the treatment of this disease. In this case report, the use of subcutaneous ivermectin is described as a successful therapy for this life-threatening infection.

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Antiparasitic Agents / administration & dosage*
  • Humans
  • Immunocompromised Host
  • Ivermectin / administration & dosage*
  • Male
  • Middle Aged
  • Salvage Therapy
  • Strongyloides stercoralis
  • Strongyloidiasis / diagnosis
  • Strongyloidiasis / drug therapy*
  • Treatment Outcome


  • Antiparasitic Agents
  • Ivermectin